Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bantilan KS"'
Autor:
Gurumurthi A; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bantilan KS; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hamlin PA; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kumar A; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Matasar M; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Zhu M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Joseph A; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Castro A; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Biggar E; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Salles G; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zelenetz AD; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., von Keudell G; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Beth Israel Deaconess Cancer Center, Boston, MA, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep 20, pp. 1-4. Date of Electronic Publication: 2024 Sep 20.
Autor:
Bantilan KS; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Smith AN; Department of Quantitative Sciences, Mayo Clinic, Rochester, MN., Maurer MJ; Department of Quantitative Sciences, Mayo Clinic, Rochester, MN., Teruya-Feldstein J; HistoWiz, Long Island City, NY., Matasar MJ; Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Moskowitz AJ; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Straus DJ; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Noy A; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Palomba ML; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Horwitz SM; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Hamlin PA; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Portlock CS; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY., Cerhan JR; Department of Quantitative Sciences, Mayo Clinic, Rochester, MN., Habermann TM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Salles GA; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Nowakowski GS; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Moskowitz CH; Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Zelenetz AD; Department of Medicine, Division of Hematologic Malignancies, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.
Publikováno v:
Blood advances [Blood Adv] 2024 May 14; Vol. 8 (9), pp. 2172-2181.
Autor:
Bantilan KS; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kay NE; Mayo Clinic College of Medicine, Rochester, MN, USA., Parikh SA; Mayo Clinic College of Medicine, Rochester, MN, USA., Rabe KG; Mayo Clinic College of Medicine, Rochester, MN, USA., Call TG; Mayo Clinic College of Medicine, Rochester, MN, USA., Leis JF; Mayo Clinic College of Medicine, Scottsdale, AZ, USA., Ding W; Mayo Clinic College of Medicine, Rochester, MN, USA., Slager SL; Mayo Clinic College of Medicine, Rochester, MN, USA., Soumerai JD; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mato A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 300-311. Date of Electronic Publication: 2022 Dec 12.
Autor:
Thompson MC; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Harrup RA; Royal Hobart Hospital, Tasmania, Australia., Coombs CC; University of North Carolina, Chapel Hill, NC., Roeker LE; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Pu JJ; University of Arizona Cancer Center, Tuscon, AZ., Choi MY; University of California, San Diego, San Diego, CA., Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Allan JN; Weill Cornell Medicine, New York, NY., Šimkovič M; University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Leslie L; Hackensack University Medical Center, Hackensack, NJ., Rhodes J; Northwell Health Cancer Institute, Lake Success, NY., Chong EA; University of Pennsylvania, Philadelphia, PA., Kamdar M; University of Colorado Cancer Center, Denver, CO., Skarbnik A; Novant Health, Charlotte, NC., Lansigan F; Dartmouth-Hitchcock Medical Center, Lebanon, NH., McCall B; Dartmouth-Hitchcock Medical Center, Lebanon, NH., Saja K; Colchester General Hospital, East Suffolk, and North Essex NHS Foundation Trust, Essex, United Kingdom., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom., Walter HS; The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom., Lefebure M; Roche Products Ltd, Welwyn Garden City, United Kingdom., Thadani-Mulero M; Roche Products Ltd, Welwyn Garden City, United Kingdom., Boyer M; Roche Products Ltd, Welwyn Garden City, United Kingdom., Biondo J; Genentech, Inc., South San Francisco, CA., Sail K; AbbVie, Inc., North Chicago, IL., Manzoor BS; AbbVie, Inc., North Chicago, IL., Furman R; Weill Cornell Medicine, New York, NY., Bantilan KS; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Goy A; Hackensack University Medical Center, Hackensack, NJ., Feldman T; Hackensack University Medical Center, Hackensack, NJ., Labella D; Riverside Regional Medical Center, Newport News, VA., Schuster SJ; University of Pennsylvania, Philadelphia, PA., Park J; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Palomba L; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Zelenetz A; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Kater AP; Amsterdam University Medical Centers, Amsterdam, The Netherlands; and., Seymour JF; Royal Melbourne Hospital, Peter McCallum Cancer Centre, and University of Melbourne, Melbourne, Australia., Mato AR; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
Publikováno v:
Blood advances [Blood Adv] 2022 Aug 09; Vol. 6 (15), pp. 4553-4557.
The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma.
Autor:
Fischer T; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; A. C. Camargo Cancer Center, São Paulo, Brazil., Ni A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; College of Public Health, The Ohio State University, Columbus, OH, USA., Bantilan KS; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Soumerai JD; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Alperovich A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Batlevi C; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Younes A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Mar; Vol. 63 (3), pp. 573-582. Date of Electronic Publication: 2022 Feb 03.
Autor:
Kumar A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: kumara2@mskcc.org., Bantilan KS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Jacob AP; Adaptive Biotechnologies, Seattle, WA., Park A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Schoninger SF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Sauter C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Ulaner GA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Casulo C; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Faham M; Adaptive Biotechnologies, Seattle, WA., Kong KA; Adaptive Biotechnologies, Seattle, WA., Grewal RK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Gerecitano J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hamilton A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hamlin P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Matasar M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Moskowitz CH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Noy A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Palomba ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Portlock CS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Younes A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Willis T; Adaptive Biotechnologies, Seattle, WA., Zelenetz AD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Apr; Vol. 21 (4), pp. 230-237.e12. Date of Electronic Publication: 2021 Jan 01.
Autor:
Soumerai JD; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Ni A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alperovich A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Batlevi C; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bantilan KS; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fischer T; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Copeland AR; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Smith K; Royal Marsden Hospital, London, UK., Ying Z; Peking University Cancer Hospital, Beijing, China., Younes A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (12), pp. 2939-2946. Date of Electronic Publication: 2020 Jul 15.
Autor:
Shah GL; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. shahg@mskcc.org., Yahalom J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Matasar MJ; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Verwys SL; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Goldman DA; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bantilan KS; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang Z; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., McCall SJ; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Moskowitz AJ; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Moskowitz CH; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2016 Nov; Vol. 175 (3), pp. 440-447. Date of Electronic Publication: 2016 Jul 05.